Abstract
Patients with post-COVID-19-related symptoms require active and timely support in self-management. Just-in-time adaptive interventions (JITAI) seem promising in meeting these needs, as they aim to provide tailored interventions based on patient-centred measures. This systematic scoping review explores the suitability and examines key components of a potential JITAI in post-COVID-19 syndrome. Databases (PsycINFO, PubMed, and Scopus) were searched using terms related to post-COVID-19-related symptom clusters (fatigue and pain; respiratory problems; cognitive dysfunction; psychological problems) and to JITAI. Studies were summarised to identify potential components (interventions options, tailoring variables and decision rules), feasibility and effectiveness, and potential barriers. Out of the 341 screened records, 11 papers were included (five single-armed pilot or feasibility studies, three two-armed randomised controlled trial studies, and three observational studies). Two articles addressed fatigue or pain-related complaints, and nine addressed psychological problems. No articles about JITAI for respiratory problems or cognitive dysfunction clusters were found. Most interventions provided monitoring, education or reinforcement support, using mostly ecological momentary assessments or smartphone-based sensing. JITAIs were found to be acceptable and feasible, and seemingly effective, although evidence is limited. Given these findings, a JITAI for post-COVID-19 syndrome is promising, but needs to fit the complex, multifaceted nature of its symptoms. Future studies should assess the feasibility of machine learning to accurately predict when to execute timely interventions.
Author Summary Patients with post-COVID-19 syndrome (PCS) experience a lot of various, continuously fluctuating symptoms. Certain mobile health technologies, such as just-in-time adaptive intervention (JITAI), may help in dealing with these symptoms, and have been utilised in other health conditions. In this study, we investigate to what extent it would be possible to develop a JITAI for post-COVID-19 and what that would look like based on 11 existing JITAI-related articles. We found evidence for JITAI being helpful to deal with psychological problems (such as depression) and to a lesser extent with aspects of fatigue, using sensing technologies or user-reported variables. Our findings suggest that JITAI have potential to help PCS patients. However, more research is necessary to develop a JITAI to help patients deal with other symptoms (such as cognitive problems and breathing difficulties), as well as on how to predict when interventions can occur at the right time for fatigue. These findings may also be helpful to develop interventions in other disorders, such as chronic fatigue syndrome.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos